Sugi Predict

Sugi Predict / Compounds / SCHEMBL2201605

SCHEMBL2201605

SCHEMBL2201605

CC(=O)Oc1cccc(-c2cc(-c3ccncc3)[nH]c(=O)c2C#N)c1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.53
▸ MET P08581 5/20 0.49
▸ KDR P35968 5/20 0.49
▸ PIM1 P11309 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ GLA P06280 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ BIRC5 O15392 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2203015 0.96 ATM (0.53) ATMMETKDRPIM1KDM4E
SCHEMBL2203539 0.87 MET (0.51) ATMMETKDRPIM1KDM4E
SCHEMBL2200432 0.81 ATM (0.61) ATMMETKDRPIM1KDM4E
SCHEMBL2201652 0.80 KDM4E (0.43) ATMKDM4EGLAMEN1RECQL
SCHEMBL2203770 0.79 MEN1 (0.56) ATMMETKDRPIM1KDM4E
SCHEMBL2203082 0.78 GAA (0.43) ATMPIM1KDM4EGLAALDH1A1
SCHEMBL2203345 0.77 PIM1 (0.62) ATMMETKDRPIM1BIRC5
SCHEMBL2201383 0.77 PIM1 (0.55) ATMMETKDRPIM1KDM4E
SCHEMBL2200264 0.76 MAOB (0.39) ATMPIM1KDM4EGLAALDH1A1
SCHEMBL2202897 0.72 SQOR (0.49) PIM1KDM4EGLAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents MAP4K2, ABL1, MAP4K3 ATM 314/4885MET 856/4885KDR 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.